Immune-inflammatory predictors of the pelvic pain syndrome associated with adenomyosis

Gynecol Endocrinol. 2017;33(sup1):44-46. doi: 10.1080/09513590.2017.1399696.

Abstract

The aim of the study was the analysis of immune inflammatory processes in the development of the pelvic pain syndrome associated with adenomyosis. For morphological examination were used 54 fragments of the myometrium obtained from patients after hysterectomy with pelvic pain on a background of diffuse adenomyosis of II-III degree, and 20 patients with painless form of adenomyosis. The identification of the macrophages distribution was held by means of an immune-hysto-chemical analysis of MAT (monoclonal antibody) for CD68. (Clone PG-M1, 'Diagnostic BioSystems', USA). The results of the study showed a significantly higher expression of CD68 (49.3 ± 2.3 vs. 21.2 ± 1.7 units. p < .01) in patients with painful adenomyosis form in areas of the ectopic endometrium, in the perivascular regions of the myometrium, as compared to those areas in women with painless group. We assume that these factors increase neurogenic inflammation and sensitivity of nociceptors in myometrium, activation of peripheral nerve fibers and, can act as triggers of the pelvic pain syndrome associated with adenomyosis.

Keywords: Adenomyosis; chronic pelvic pain syndrome; neurogenic inflammation.

MeSH terms

  • Adenomyosis / complications*
  • Adenomyosis / metabolism
  • Antigens, CD / metabolism
  • Antigens, Differentiation, Myelomonocytic / metabolism
  • Biomarkers / metabolism
  • Female
  • Humans
  • Inflammation / metabolism
  • Lymphocytes / metabolism
  • Macrophages / metabolism
  • Myometrium / metabolism*
  • Pelvic Pain / etiology*
  • Pelvic Pain / metabolism

Substances

  • Antigens, CD
  • Antigens, Differentiation, Myelomonocytic
  • Biomarkers
  • CD68 antigen, human